
Lectures by Invitation

9/13/2023 | Humanitas university, Milan. The complement system at the forefront of novel immunotherapies. |
6/2/2023 | 18th International Conference on Innate Immunity, Chania, Greece. The dawn of clinical C3 inhibition: the story, its milestones and what lies ahead. |
5/27/2023 | 15th International Conference on Complement Therapeutics, Chania, Greece.The dawn of clinical C3 inhibition: the story, its milestones and what lies ahead. |
6/23/2022 | 14th International Conference on Complement Therapeutics. Rhodes Greece. Taking C3 inhibition to the next level: new insights and clinical opportunities. |
10/21/2021 | Penn Dental Medicine-Frontiers in Science. C3-targeted therapy in periodontal disease: moving closer to the clinic. |
9/9/2021 | 13th International Conference on Complement Therapeutics, Ioannina, Greece. Clinical development of the compstatin-based C3 therapeutic AMY-101 as a novel host modulation therapy for periodontal inflammation. |
5/14/2021 | 200 years of the Greek World and Neurosciences. Complement Therapeutics: Missconceptions, Myths and novel Insights. |
12/12/2020 | 100th Anniversary of Jules Bordet's Nobel Prize, Royal Academy of Medicine of Belgium. The complement system at the forefront of novel immunotherapies. YouTube |
12/10/2020 | 7th Panhellenic e-Congress of the Hellenic Academy of Neuroimmunology. Plenary Lecture: Targeting the complement system. Video |
6/24/2019 | 13th International Conference on Pathways, Networks, and Systems Medicine, Chania, Crete, Greece. An update on the clinical development of compstatin-based drug candidate AMY-101. |
6/13/2019 | 12th International Conference on Complement Therapeutics, Rhodes, Greece. An update on the clinical development of the compstatin-based drug candidate AMY-101. |
5/17/2019 | The New Era of Aplastic Anemia and Paroxysmal Noctrunal Hemoglobinuria, Napoli, Italy. Anti-C3: AMY-101 and other compstatins. |
8/29/2018 | University Hospital, University of Sao Paulo, Ribeirao Preto, Brazil. Innate immunity: More than a guard against invading pathogens. |
8/28/2018 | Butantan Institute, Sao Paulo, Brazil. Innate immunity: More than a guard against invading pathogens. |
7/24/2018 | 11th International Conference on Complement Therapeutics, Chania, Crete, Greece. An update on the clinical development of compstatin (AMY-101). |
3/10/2018 | University of Athens Medical School, Department of Pathology-Nephrology. Complement therapeutics. |
9/11/2017 | University of Malmo, Malmo, Sweden. Development of pharmacological interventions against complement factor C3 and potential indications in renal medicine and transplantation. |
9/8/2017 | C3G Satellite Meeting, Copenhagen, Denmark. Targeting C3. |
9/6/2017 | University of Ulm, Ulm, Germany. News in the world of complement research. |
6/30/2017 | 12th International Conference on Pathways, Networks, and Systems Medicine, Heraklion, Crete, Greece. Status of complement therapeutics. |
6/27/2017 | 10th International Conference on Complement Therapeutics. Compstatin Cp40 (AMY101): A C3 complement inhibitor reaching its prime for bedside intervention, Heraklion, Crete, Greece. |
6/21/2017 | 14th International Conference on Innate Immunity, Heraklion, Crete, Greece. Therapeutic complement inhibition at the level of C3: microconceptions, myths, and novel insight. |
9/30/2016 | 2nd International Conference on Immune Responses to Biosurfaces: Mechanisms and Therapeutic Interventions, Ixia, Rhodes, Greece. Compstatin Cp40 (AMY-101): A C3 targeted complement inhibitor reaching its prime for bedside intervention. |
6/29/2016 | 9th International Conference on Complement Therapeutics, Ixia, Rhodes, Greece. Compstatin Cp40 (AMY-101): A C3 targeted complement inhibitor reaching its prime for bedside intervention. |
6/25/2016 | 13th International Conference on Innate Immunity, Ixia, Rhodes, Greece. Compastatin Cp40 (AMY-101): A C3 targeted complement inhibitor reaching its prime for bedside intervention. |
11/18/2015 | IPITA, IXA, CTS Joint Congress, Melbourne, Australia. New reagents to regulate complement activation. |
9/2/2015 | 8th International Conference on Complement Therapeutics, Chania, Crete, Greece. An update on the preclinical and clinical development of the therapeutic C3 inhibitor Cp40. |
8/11/2015 | 12th World Congress on Inflammation, Boston, MA, USA. Compstatin CP40: An immune modulator on a journey from disease models to clinical development. |
8/9/2015 | 12th World Congress on Inflammation, Boston, MA, USA. Complement: More than a "guard" against pathogens. |
6/21/2015 | 12th International Conference on Innate Immunity, Chania, Crete, Greece. Compstatin Cp40: An immune modulator on a journey from disease models to clinical development. |
5/3/2015 | State of the Art Speaker, American Transplantation Conference, Philadelphia, PA, USA. Complement: More Than a "guard" against pathogens. |
1/9/2015 | University of Florence, Italy. Complement: More than a "guard" against pathogens. |
9/29/2014 | 1st International Conference on Immune Responses to Biosurfaces: Mechanisms and Therapeutic Interventions, Chania, Crete, Greece. Cp40: A complement inhibitor getting ready for primetime. |
6/5/2014 | 11th International Conference on Innate Immunity, Olympia, Greece. Complement C3 ihibitors getting ready for primetime: Compstatin Cp40 in local and systemic applications. |
5/22/2014 | Linneaus University Center for Biomaterials Chemistry, Kalmar, Sweden. Therapeutic complement inhibition at the level of C3: microconceptions, myths, and novel insight. |
4/9/2014 | Institute for Systemic Inflammation Research, Luebeck University, Luebeck, Germany. Innate immunity: More than a guard against invading pathogens. |
3/27/2014 | Aplastic Anemia & MDS International Foundation. Bone Marrow Failure Disease Scientific Symposium, Rockville, MD. Rational and preclinical development of novel strategy of complement inhibition. |
8/25/2013 | 15th International Congress of Immunology, Milan, Italy. The renaissance of complement. |
6/27/2013 | 10th International Conference on Innate Immunity, Kos, Greece. Preclinical development of compstatin: Progress, applications, and insight about therapeutic complement inhibition at the level of C3. |
6/19/2013 | 6th International Conference on Complement Therapeutics, Kos, Greece. Therapeutic complement inhibition at the level of C3: Microconceptions, myths, and novel insight. |
1/24/2013 | Rudbeck Seminar, Uppsala University, Sweden. Innate immunity: More than a guard against invading pathogens. |
1/18/2013 | 15th Rheumatology Scientific Meeting of the Northwestern Greece, Ioannina, Greece. Innate immunity: More than a "guard" against pathogens. |
1/17/2013 | Medical and Dental Societies, Agrinion, Greece. Microbes: Friends or Foes? |
1/16/2013 | EKFE, Arta, Greece. Microbes: Friends or Foes? |
1/12/2013 | Balances: Basic Knowledge and Development in Hematology, Ioannina, Greece. Innate Immunity: Therapeutic approaches with emphasis on hematological diseases. |
10/13/2012 | XXIV International Complement Workshop, Chania, Crete, Greece. Bringing compstatin to the next level: Novel analogs with improved potency, pharmacokinetic profiles and administration options suitable for systemic application. |
10/8/2012 | Tumor Microenvironment and Cellular Stress: Signaling, Metabolism, Imaging and Therapeutic Targets, Chania, Crete, Greece. Shifting a paradigm? Unexpected functions of complement in cancer. |
6/26/2012 | 9th International Conference on Innate Immunity, Rhodes, Greece. Compstatin: A complement inhibitor on its way to clinical application. |
6/8/2012 | 13th Naples Workshop on Bioactive Peptides, Naples, Italy. Peptide based complement inhibitors: From bench to bedside. |
2/21/2012 | Sanquin Blood Supply Foundation, Dept. of Immunopathology, Amsterdam, The Netherlands. Innate immunity: More than a "guard" against invading pathogens. |
11/8/2011 | State of the Art lecture, ACR/ARHP Annual Scientific Meeting, Chicago. Complementary roles for complement in rheumatic diseases. |
10/26/2011 | Dept. di Biochimica e Biotecnologie Mediche, Dept. Assistenziale di Clinica Medica, Universita di Napoli Federico II. Innate immunity: More than a "guard" against invading pathogens. |
10/25/2011 | Instituto di Biostrutture e Bioimmagini, Consiglio Nazionale delle Ricerche, Naples, Italy. Structure and function of complement proteins and design of complement inhibitors. |
10/21/2011 | Department of Medicine, Division of Allergy and Immunology, University of Pennsylvania. Innate immunity: More than a "guard" against invading pathogens. |
10/6/2011 | Department of Ophthalmology, University of Pennsylvania. Innate immunity: More than a "guard" against invading pathogens. |
10/5/2011 | Center for Research on Reproduction and Women's Health, University of Pennsylvania Perelman School of Medicine. Innate immunity: More than a "guard" against invading pathogens. |
9/14/2011 | 4th International Conference on Crossroads between Innate and Adaptive Immunity, Mykonos, Greece. A keystone biological system for immune surveillance and homeostasis. |
6/23/2011 | 5th International Complement Therapeutics Conference, Rhodes, Greece. An update on compstatin. |
6/17/2011 | 8th International Innate Immunity Workshop, Crete, Greece. Innate immunity: More than a "guard" against invading pathogens. |
6/14/2011 | 9th International Conference on Pathways, Networks and Systems Medicine, Crete, Greece. Innate immunity: More than a "guard" against invading pathogens. |
4/8/2011 | City University of Hong Kong. Innate immunity: More than a "guard" against invading pathogens. |
3/4/2011 | Systems Biology Institute, Seattle. Innate immunity: More than a "guard" against invading pathogens. |
1/19/2011 | The University of Chicago, Committee on Microbiology Seminar Series. The renaissance of complement. |
12/2/2010 | Department of Molecular Microbiology and Immunology, Brown University. The renaissance of complement. |
10/2/2010 | 1st Biennial Symposium on AMD, Harvard Medical School, Boston. Complement therapeutics. |
9/16/2010 | Somalogic, Boulder, Colorado. A "multidisciplinary" approach to understand disease and pathogenesis and develop therapeutics. |
3/29/2010 | 3rd Joint Conference of the German Society for Hygiene and Microbiology (DGHM) e.V. and the Association for General and Applied Microbiology (VAAM), Hanover, Germany. The renaissance of complement. |
11/28/2009 | 1st International Conference on Molecular Cancer Research, Athens, Greece. Shifting the paradigm. Unexpected functions of complement in cancer. |
11/27/2009 | National Academy of Athens, Greece. Innate immunity. |
11/11/2009 | University of Michigan, Department of Pathology. The renaissance of complement. |
10/27/2008 | Department of Pathology and Laboratory Medicine, University of Pennsylvania. System biology approaches to disease pathogenesis and development of therapeutics. |
1/18/2008 | Division of Allergy and Immunology, University of Pennsylvania. Complement therapeutics. |
10/26/2007 | Durham, NC. 1st Annual DIRECT Dry AMD Meeting. Complement biology and biochemistry. |
10/19/2007 | Department of Neurology Thomas Jefferson University. Systems approaches to disease pathogenesis and development of therapeutics. |
9/25/2007 | Department of Crystal and Structural Chemistry, Bijvoet Centre for Bimolecular Research, Utrecht University. The structures and functions of the complement system. |
6/24/2007 | 5th International Conferences on Pathways, Networks, and Systems: Theory and Experiments, Porto Heli, Greece. Systems approaches to disease pathogenesis and development of therapeutics. |
6/13/2007 | 4th Workshop on Complement Associated Diseases, Animal Models, and Therapeutics,Porto Heli, Greece. Novel complement therapeutics. |
6/5/2007 | 4th International Leukocyte Signal Transduction Workshop: Clinical implications of signaling pathways, Rhodes, Greece. Systems approaches to disease pathogenesis and development of therapeutics. |
4/23/2007 | 2nd Biosciences Congress, University of Patras, Greece. Plenary lecture on "The today’s challenges in biosciences." |
4/19/2007 | 41st Annual Scientific Meeting of the European Society for Clinical Investigation, Uppsala, Sweden. Interference with complement activation. |
2/6/2007 | Stem Cell Biology Program, James Graham Brown Cancer Center University of Louisville. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences. |
12/7/2006 | Division of Cell Biology and Biophysics, University of Missouri-Kansas City. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences. |
12/5/2006 | GTCBio’s - Medicinal Chemistry at the 2nd Modern Drug Discovery & Development, Philadelphia, PA. Complement inhibitors: From bench to bedside. |
10/17/2006 | 4th International Conferences on Pathways, Networks, and Systems: Theory and Experiments, Mykonos, Greece. A "multidisciplinary" approach to understand disease pathogenesis and develop therapeutics. |
6/30/2006 | 1st International Conference on Ovarian Cancer: State of the Art and Future Directions, Crete, Greece. From atoms to systems: A "multidisciplinary" approach to understand disease pathogenesis and develop therapeutics. |
6/7/2006 | 4th Innate Immunity Conference, Corfu, Greece. Protein-protein interactions in the complement system and development of complement therapeutics. |
5/11/2006 | University of Kalmar, Sweden. The today’s challenges in biosciences. |
5/8/2006 | Department of Clinical Immunology, University of Uppsala, Sweden. A "multidisciplinary" approach to today’s challenges in biosciences. |
3/15/2006 | Department of Chemical Engineering and Materials Science, University of Minnesota. Rational design of complement therapeutics. |
10/11/2005 | Grossroads between Innate and Adaptive Immunity, Rhodes, Greece. Integrating innate immunity into a "systems context"; The complement paradigm. |
10/4/2005 | 3rd International Conference on Pathways, Networks and Systems: Theory and Experiments, Rhodes, Greece. Integrating innate immunity into a "systems context"; The complement paradigm. |
9/10/2005 | 13th Signal and Signal Processing in the Immune System. EFIS Conference, Balatonöszöd, Hungary. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences. |
6/7/2005 | 3rd Workshop on Complement Associated Diseases, Animal Models, and Therapeutics, Rhodes, Greece. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences. |
5/31/2005 | 3rd Lymphocyte Signal Transduction Workshop, Crete, Greece. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences. |
5/25/2005 | 2nd International Conference on Tissue Engineering, Crete, Greece. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences. |
5/20/2005 | BIOMED Seminar, Engineering School Drexel University. From atoms to systems: A "multidisciplinary" approach to today’s challenges in biosciences. |
5/12/2005 | FOCIS, Boston, MA. A multidisciplinary approach to complement functions. |
3/17/2005 | Philadelphia's Science Center. From atoms to systems: A multidisciplinary approach to today's challenges in biosciences. |
3/9/2005 | Department of Immunology, Beijing Medical School, China. From atoms to systems: A multidisciplinary approach to today's challenges in biosciences. |
1/31/2005 | Computer Science Department, School of Computer Science, Carnegie Mellon. From atoms to systems: A multidisciplinary approach to today’s challenges in Biosciences. |
12/21/2004 | Department of Pathology, University of Michigan. A multidisciplinary approach to today’s challenges in biosciences. |
12/15/2004 | Department of Pathology, School of Dental Medicine, University of Pennsylvania. A "cross-disciplinary" approach to complement mediated functions. |
12/12/2004 | Department of Pathology, Columbia University. Complement: More than a "guard" against invading pathogens. |
9/10/2004 | FEBS Immunology Summer Course, Killini, Greece. Complement: More than a "guard" against invading pathogens. |
7/14/2004 | Foundations of Computer Aided Process Design (FOCAPD): Design through product and process design. De novo protein design: An interplay of global optimization, mixed-integer optimization and experiments. |
5/3/2004 | Department of Genetics, Case Western Reserve University, Cleveland, OH. A "multidisciplinary" approach to today’s challenges in biosciences. |
4/28/2004 | Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison. A "multidisciplinary' approach to complement mediated functions. |
4/22/2004 | 4th Orthopoxvirus Meeting, Washington DC. Vaccinia-host interactions. |
3/2/2004 | Enrique E. Ecker Memorial Lecture, Case Western Reserve University, Cleveland, OH. From atoms to systems: A "cross-disciplinary" approach to complement mediated functions. |
1/22/2004 | PENN center for Clinical Immunology, Seminars in Human Translational Immunology. Complement inhibitors: From bench to bedside. |
12/8/2003 | Department of Pathology, University of Pennsylvania. From atoms to systems: A "metadisciplinary" approach to innate immunity. |
12/4/2003 | NIH/NIEHS Science Retreat on Comparative Systems Biology Approaches as Applied to Environmental Health. A systems biology analysis of innate immunity. |
11/28/2003 | Departments of Biotechnology/Chemistry/Pharmacology, University of Modena, Italy. From atoms to systems: A "metadisciplinary" approach to innate immunity. |
11/24/2003 | Division of Rheumatology, University of Pennsylvania. A systems biology analysis of innate immunity. |
10/21/2003 | SOL Sherry Thrombosis Research Center, Temple University. A systems biology analysis of innate immunity. |
9/30/2003 | Aegean Conferences on Pathways, Networks, and Systems: Theory and Experiments, Santorini, Greece. A systems biology analysis of complement functions. |
9/16/2003 | South Jersey ACS Meeting. Rational design of complement inhibitors. |
9/9/2003 | Biochemical Society Focused Meeting, Stevenage, UK. Design of inhibitors for proteolytic cascades. Rational design of complement inhibitors. |
8/3/2003 | Baoding High Tech Developing Zone, China. Design of complement inhibitors. |
6/10/2003 | 15th European Immunology Congress, Rhodes, Greece. Plenary lecture on Complement: More than a "guard" against invading pathogens. |
2/17/2003 | Department of Immunology, Beijing Medical School, China. Innate immunity: More than a "guard" against invading pathogens. |
2/17/2003 | University of Patras, Patras, Greece. Design of complement inhibitors. |
2/12/2003 | University of Ioannina, Ioannina, Greece. Post genomic era challenges. |
12/10/2002 | Microbiology and Immunology Distinguished Lecture Series, University of Texas Medical Branch, Galveston, TX. Innate immunity: More than a "guard" against invading pathogens. |
11/13/2002 | Exton, PA, 3-Dimentional Pharmaceuticals. Rational design of complement inhibitors. |
6/17/2002 | 67th Meeting of British Biochemical Society, Cardiff, UK. Rational design of complement inhibitors. |
3/27/2002 | Department of Microbiology and Immunology, MCP-Drexel. Complement: More than a “guard” against invading pathogens. |
10/11/2001 | International Workshop on Complement Associated Diseases, Animal Models, and Therapeutics, Santorini, Greece. Design of complement therapeutics. |
10/10/2001 | International Workshop on Complement Associated Diseases, Animal Models, and Therapeutics, Santorini, Greece. The role of complement in developmental processes. |
10/1/2001 | Perspectives in Tunicate Biology- IV Anton Dohrn Workshop, Ischia, Italy. The role of complement in developmental processes. |
6/22/2001 | The 5th Nordic Symposium on Fish Immunology, Sundvollen, Norway. Structure and functions of trout complement proteins. |
2/20/2001 | Instituto Tecnologie Biomedichemie, CNR, Rome Italy. Therapeutic interventions in the complement system. |
2/16/2001 | Stazione Zoologica, Napoli, Italy. The diversity and evolution of innate immunity. |
2/2/2001 | Immunology Lecture series, Cornell University, Veterinary School, Ithaca, NY. Complement: New horizon. |
1/12/2001 | ICOS Corporation, Bothell, WA. Protein-protein interactions in the complement system and design of complement inhibitors. |
12/6/2000 | Pathology Lecture Series. University of Wisconsin-Madison. Protein-protein interactions in the complement system and design of complement inhibitors. |
7/10/2000 | St. George Hospital, Department of Immunology, Allergy & Infectious Diseases, University of New South Wales, Australia. Therapeutic potential of compstatin. |
10/25/1999 | EU Advanced Workshop in Biotechnology- Genome Sequence and Comparative Analysis, Thessaloniki, Greece. High throughput protein analysis: Proteomics and combinatorial chemistry. |
10/4/1999 | Pharmacology Seminar, Dep. of Pharmacology, Univ. of Pennsylvania, PA. Therapeutic potential of compstatin: A novel complement inhibitor isolated from a phage library. |
7/15/1999 | FASEB Summer Research Conference on Phylogenetic Perspectives on the Vertebrate Immune System. Complement phylogeny and diversity. |
4/1/1999 | Millennium Biotherapeutics, Boston. Therapeutic potential of compstatin. |
11/11/1998 | Marine Biotechnology Center, University of Maryland Special, Baltimore. Complement diversity. |
11/3/1998 | Division of Hematology & Oncology, CHOP, Philadelphia, PA. Inhibition of complement and cellular activation in whole blood in extracorporeal circulation by Compstatin. |
5/23/1998 | Special Symposium on Biotechology – Athens Greece. The use of combinatorial libraries in the drug discovery process. |
5/13/1998 | University of Ioannina, Greece. The use of combinatorial libraries in the drug discovery process. |
5/7/1998 | 24th Panhellenic Medical Congress, Athens-Greece. The future xenotransplant. |
12/4/1997 | University of Thessaloniki, Greece. Therapeutic potential of Compstatin; a novel complement inhibitor. |
12/2/1997 | University of Patras, Greece. Therapeutic potential of Compstatin; a novel complement inhibitor. |
11/12/1997 | University of Oslo, Norway. Therapeutic potential of Compstatin; a novel complement inhibitor. |
10/16/1997 | IBC’s 3rd Annual Meeting, Washington D.C. Controlling the complement system. Complement inhibitor interfering with C3-ligand interactions. |
5/2/1997 | Institute of Molecular Medicine, UTC, Huston, TX. Complement and viral molecular mimicry. |
10/18/1996 | SangStat, Menlo Park, CA. A novel complement inhibitor isolated from a 7 phage-displayed random peptide library. |
5/24/1996 | Amgen Corporation, Boulder, Co. Protein-protein interactions in the complement system and viral molecular mimicry. |
5/23/1996 | University of Colorado, Department of Medicine, Denver, Co. Protein-protein interactions in the complement system and viral molecular mimicry. |
10/26/1995 | Children’s Hospital of Philadelphia, Division of Pulmonary Medicine. Molecular interactions in the complement system and viral molecular mimicry. |
3/23/1995 | Aristotelian University of Thessaloniki, Department of Pharmacology, Greece. Protein-protein interactions in the complement system and viral molecular mimicry. |
3/21/1995 | Institute Pasteur, Athens, Greece. Protein-protein interactions in the complement system and viral molecular mimicry. |
3/20/1995 | University of Patras, Department of Microbiology. Protein-protein interactions in the complement system and viral molecular mimicry. |
12/7/1994 | Umea University-Sweden, Medical School. Evasion strategies of microorganisms. |
2/8/1994 | University of Louisville, Department of Microbiology & Immunology. Structure, functioning and evolution of the third component of complement. |
1/19/1994 | Chiron Co., Emeryville, CA. Critical Care Seminar Series. Design of complement inhibitors. |
11/11/1993 | Alexion Co., New Haven, CT. Protein-protein interactions in the complement system and design of complement inhibitors. |
5/24/1993 | AAI Meeting, Denver, Co. Phylogenetic analysis of C3. |
3/9/1993 | Temple University, Department of Microbiology & Immunology. Protein-protein interactions in the complement system. |
2/3/1993 | University of Pennsylvania, Research Center in Oral Medicine. Protein-protein interactions in the complement system. |
12/3/1992 | Umea University-Sweden, Medical School. Protein-protein interactions in the complement system. |
10/24/1992 | Fourth International Conference of Anticancer Research, Crete, Greece. Structure and functions of EBV/C3 receptors on human T lymphocytes. |
6/5/1992 | Washington University (Howard Hughes Scholar), Howard Hughes Medical Institute. Protein-protein interactions in the complement system. |
5/16/1992 | University of Patras, Department of Microbiology. Evasion Strategies of Microorganisms. |
5/14/1992 | Second World Conference of the Hellenic Bio-medical Diaspora, Athens, Greece. Structure, functions and phylogeny of C3. |
5/11/1992 | University of Pennsylvania, Division of Laboratory Medicine. Structure and functions of complement proteins. |
8/28/1991 | 25 Years of Biology in Patras, University of Patras, Department of Biology, Symposium. Structure, functions and phylogeny of the complement system. |
3/6/1991 | University of Pennsylvania, Department of Pediatrics, Division of Infectious Diseases and Immunology. Evasion Strategies of Microorganisms. |
10/23/1990 | University of Pennsylvania, Department of Obstetrics and Gynecology. Molecular aspects of the C3 interactions with other complement components and complement receptors. |
10/9/1990 | University of Pennsylvania, Immunology Colloquium. Molecular aspects of the C3 interactions with other complement components and complement receptors. |
9/27/1990 | University of Pennsylvania, Department of Chemistry. Protein-protein interactions in the complement system. |
2/3/1990 | Institute for Tropical Diseases, Hamburg, Germany. Protein-protein interactions. |
12/14/1989 | Aristotelian University of Thessaloniki, Department of Pharmacology, Greece. Protein-protein interactions. |
12/7/1989 | University of Heidelberg, Institute of Immunology, Heidelberg, FRG. The multifunctional role of the third component of complement. |
2/2/1989 | University of Lausanne, Department of Biochemistry, Lausanne, Switzerland. Structure and functions of the third component of complement. |
1/20/1989 | University of Pennsylvania, Department of Pathology and Laboratory Medicine. The complement system as a model system to study protein-protein interactions. |
3/24/1988 | University of Innsbruck, Institute for Hygiene, Innsbruck, Austria. The multifunctional role of the third component of complement. |
2/16/1988 | Autoimmune Disease Center, Scripps Clinic and Research Foundation, La Jolla. Molecular aspects of the C3 interactions with complement receptors and other complement components. |
2/11/1988 | Molecular Biology Institute, SDSU, San Diego. Molecular aspects of the C3 interactions with complement receptors and other complement components. |
2/2/1988 | Institute Pasteur, Athens, Greece. The complement system as a model to study protein-protein interactions. |
6/11/1987 | Peptide synthesis Seminar ABI, Basel. Synthetic peptides: A tool to study protein-protein interactions. |
6/5/1987 | Institute of Molecular Biology, University of Madrid, Spain. The complement system: A model to study protein-protein interactions. |
5/15/1987 | International Titisee Conferences on Proteolytic processing and biological functions. Proteolytic processing of human C3 and its interactions with complement receptors. |
4/28/1987 | Institute Pasteur, Athens, Greece. The complement system. |
1/29/1987 | Institute of Clinical Immunology, Inselspital, University of Bern. The complement system. |
12/17/1986 | Department of Biology, Roche, Basel. Molecular interactions in the complement system. |
9/19/1986 | FEBS Summer School (Advanced course) on Immunological Methods and Applications, Göd, Hungary. Molecular interactions in the complement system. |
5/30/1986 | University of Texas at Houston, M. D. Anderson Hospital, Dept. of Immunology. The multifunctional role of the third component of complement. |
12/9/1985 | Aristotelian University of Thessaloniki, Department of Pharmacology, Greece. Molecular aspects of the C3 interaction with other complement components and complement receptors. |
9/16/1985 | Basel Institute for Immunology, Basel, Switzerland. Molecular aspects of the C3 interaction with other complement components and complement receptors. |
8/27/1985 | National Institutes of Health/Kidney Disease Section Seminar. Molecular aspects of the C3 interaction with other complement components and complement receptors. |
4/9/1985 | Immunology and Gesellschaft für Immunologie, Lake Balaton, Hungary. 4th Balaton Meeting on "Signals and signal processing in the immune system" Organized by The Hungarian Society for "Molecular aspects of the C3 interaction with CR2, CR3, Factor H and bovine conglutinin". |
1/25/1985 | Aristotelian University of Thessaloniki, Greece, Department of Biology. The use of monoclonal antibodies in Biomedical Sciences. |
1/24/1985 | Aristotelian University of Thessaloniki, Greece, Department of Biology. The complement system. |
10/29/1984 | Special workshop on complement receptors, Coconut Grove, Florida. Molecular aspects of the C3 interaction with complement receptors. |
2/24/1984 | University of Ioannina, Greece, Department of Medicine. Interaction of C35 fragments with complement receptors and regulatory proteins. |
2/22/1984 | University of Innsbruck, Institute for Hygiene, Innsbruck, Austria. Mapping of the properdin C5 and C3dR binding sites on the third component of complement. |
2/21/1984 | University of Heidelberg, Institute of Immunology, Heidelberg, FRG. Interaction of C3 fragments with complement receptors and regulatory proteins. |
2/20/1984 | Johannes-Gutenberg University Institute for Medical Microbiology, Mainz, FRG. Interaction of C3 fragments with complement receptors. |
9/15/1981 | Duke University Medical Center, Department of Medicine and Pathology. Complement Receptors. |
7/13/1981 | University of Lausanne, Department of Biochemistry, Lausanne, Switzerland. Isolation and characterization of three different complement receptors. |